Splenectomy following JAK1/JAK2 inhibitor therapy in patients with myelofibrosis undergoing allogeneic stem cell transplantation-Reference-Cited by-同舟云学术

Splenectomy following JAK1/JAK2 inhibitor therapy in patients with myelofibrosis undergoing allogeneic stem cell transplantation

Published:2019-09 Issue:3 Volume:12 Page:140-145
ISSN:1658-3876
Container-title:Hematology/Oncology and Stem Cell Therapy
language:en
Short-container-title:Hematology/Oncology and Stem Cell Therapy

Author:

Barabanshikova Maria Vladimirovna,Zubarovsky Igor Nikolaevich,Savrasov Vjacheslav Mikhailovich,Korolkov Andrey Jurjevich,Baykov Vadim Valentinovich,Botina Anna Vjacheslavovna,Vlasova Julia Jurjevna,Moiseev Ivan Sergeevich,Darskaya Elena Igorevna,Morozova Elena Vladislavovna,Afanasyev Boris Vladimirovich

Publisher

Elsevier BV

Subject

Oncology,Hematology,General Medicine

Reference26 articles.

1. Clinical correlates and prognostic significance of IL-8, sIL-2R, and immunoglobulin-free light chain levels in patients with myelofibrosis;Barabanshikova;Oncol Res Treat,2017

2. Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study;Tefferi;J Clin Oncol,2011

3. New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment;Cervantes;Blood,2009

4. Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis;Kröger;Blood,2015

5. Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group;Kröger;Leukemia,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapeutic advances for splenomegaly in myelofibrosis;Expert Opinion on Pharmacotherapy;2023-03-19

2. Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis—A Systematic Review and Meta-Analysis;Transplantation and Cellular Therapy;2021-10

3. Medication guide for the perioperative management of oral antineoplastic agents in cancer patients;Expert Opinion on Drug Safety;2021-08-12

4. A provider's guide to primary myelofibrosis: pathophysiology, diagnosis, and management;Blood Reviews;2021-01

5. Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: A French nationwide study;American Journal of Hematology;2020-11-18